According to our recent findings, siRNA-mediated knockdown of pro-oncogenic RUNX2 efficiently augmented p53/TAp73-dependent cell death in p53-proficient human osteosarcoma-derived cells following DNA damage [35,136]. The gene discussed is TP53; the disease is osteosarcoma.